DVA · DaVita
S&P 500 #496 · NYSE
Risiko 5/10 · Healthcare Momentum / Policy Risk · $239.46 ▲ 1.33%
Kennzahlen
- Price $239.46
- Market cap $15.4B
- P/E (ttm) 23.09
- Div yield none
- 52-wk range $101.00 – $241.73
- Index rank #496 / —
Wichtigste Risiken
- Medicare/Medicaid reimbursement rate risk (Revenue) — HIGH
- GLP-1 drugs reducing dialysis demand long-term (Patient volumes) — MED
- Labor cost & nursing shortages (Margins) — MED
- Berkshire-driven valuation premium (Downside if sold) — MED
Fazit
Nation's largest kidney dialysis operator surging 83% YTD on raised guidance and strong Q1 beat; now trading at all-time highs, with GLP-1 disruption risk a key long-term watch item.
Recherche, keine Anlageberatung.